Implementation and evaluation of shared decision-making, supported by outcome measures, regarding the organisation of follow-up care in breast cancer

Santeon0 个研究点目标入组 630 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

.A.

•1) Patients must be facing the decision for the organisation of follow-up care after receiving curative treatment for invasive breast cancer (in the first follow-up consultation about 1 year after surgery); 2) Being treated in a Santeon hospital; 3) = 18 years of age; 4) Understand the Dutch language in speech and writing, and; 5) Able to provide informed consent.

•1) Patients diagnosed with non-invasive breast cancer (e.g. Ductal Carcinoma In Situ (DCIS)); 2) Patients who receive palliative treatment; 3) Patients who received neoadjuvant therapy; 4) Male breast cancer patients; 5) Patients with dementia; 6) Patients who received treatment for a recurrence or second primary tumor; 7) Patients with a breast cancer-related gene alteration (e.g. BRCA).

发起方